MeSH Terms
Benzenesulfonates/pharmacology,therapeutic use
Drug Screening Assays, Antitumor
Enzyme Activation/drug effects
Extracellular Signal-Regulated MAP Kinases/antagonists & inhibitors
Humans
Indoles/adverse effects,blood,pharmacology,therapeutic use
Melanoma/blood,drug therapy,genetics,pathology
Mutation/genetics
Niacinamide/analogs & derivatives
Phenylurea Compounds
Proto-Oncogene Proteins B-raf/antagonists & inhibitors,genetics,metabolism
Pyridines/pharmacology,therapeutic use
Sorafenib
Sulfonamides/adverse effects,blood,pharmacology,therapeutic use
Time Factors
Vemurafenib
Chemicals
Benzenesulfonates
Indoles
Phenylurea Compounds
Pyridines
Sulfonamides
Vemurafenib
Niacinamide
Sorafenib
Proto-Oncogene Proteins B-raf
Extracellular Signal-Regulated MAP Kinases
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Solit David
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. solitd@mskcc.org
Rosen Neal